Status:
COMPLETED
A Trial of Vitamins and HAART in HIV Disease Progression
Lead Sponsor:
Harvard School of Public Health (HSPH)
Collaborating Sponsors:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Conditions:
HIV Infections
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This study is a double-blind randomized clinical trial, conducted to examine the effects of multivitamins (including B, C, and E) on HIV disease progression among HIV-positive Tanzanian adult men and ...
Detailed Description
Access to Highly Active Anti-Retroviral Therapy (HAART) for the treatment of HIV in developing regions is limited, but gradually becoming standard of care in some countries. Multivitamin supplements h...
Eligibility Criteria
Inclusion
- HIV-positive
- Men or Women
- 18 Years of Age or older
- Initiating HAART at time of randomization
Exclusion
- Pregnant or Lactating Women
- Individuals at pre-HAART disease stages
- BMI less than 16
Key Trial Info
Start Date :
November 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2009
Estimated Enrollment :
4012 Patients enrolled
Trial Details
Trial ID
NCT00383669
Start Date
November 1 2006
End Date
October 1 2009
Last Update
July 16 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Muhimbili University College of Health Sciences
Dar es Salaam, Tanzania